Prenatal exposure to antiepileptic drugs
Few studies have examined development during the first months of life of children of mothers with epilepsy, according to background in the study by Gyri Veiby, M.D., of the University of Bergen, Norway, and colleagues.
Researchers used data from the Norwegian Mother and Child Cohort Study from 1999 to 2009, in which mothers reported children's motor and social skills, language and behavior at 6, 18 and 36 months of age. Women also provided information on breastfeeding during the first year.
Exposure to antiepileptic drugs during pregnancy was reported in 223 children, mostly to a single drug (n=182).
At age 6 months, a higher proportion of infants whose mothers took antiepileptic drugs had impaired fine motor skills compared to the reference group (11.5 percent vs. 4.8 percent). The use of multiple antiepileptic medications was associated with impaired fine motor and social skills, according to the study results.
Breastfeeding by mothers using antiepileptic drugs was not associated with adverse development at ages 6 to 36 months in nursing children, according to the study.
"Women with epilepsy should be encouraged to breastfeed their children irrespective of antiepileptic medication use," the study concludes.
Breastfeeding in momen with epilepsy
In an editorial, Paul C. Van Ness, M.D., of the University of Texas Southwestern Medical Center, Dallas, writes: "Pregnant women with epilepsy often ask whether they will be able to breastfeed. Many have been given conflicting advice when there were scant data to answer the question."
"This study adds additional evidence that long-term breastfeeding is safe and perhaps even beneficial to infants of mothers taking AEDs [antiepileptic drugs]," Van Ness continues.
"This should be an important area of discussion with any woman of childbearing potential well in advance of pregnancy using the best available information. Thus, a woman should take folic acid supplements, received AED monotherapy whenever possible, and take the lowest effective dose of medication," the editorial concludes.
Most read news
Other news from the department science
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.